Sign In
30 Sep 2008 17:06
RNS Number : 7560E
Ark Therapeutics Group PLC
30 September 2008
Β
ο»Ώ
30 September 2008Β
Ark Therapeutics Group plc
Voting Rights and Capital
In accordance with the FSA's Disclosure and Transparency Rules, Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") confirms that as at the date of this announcement the Company's issued share capital consists of 205,157,626 ordinary shares with voting rights. The Company does not hold any shares in Treasury.
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to the interest in,Β ArkΒ under the FSA's Disclosure and Transparency Rules.
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
Β
ENDΒ
Β
TVRQBLFXVKBBBBE 
Follow the stocks
